Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Minimal Effective Dose of Cis-9-cetylmyristoleate (CMO) in Persons Presenting With Knee Joint Pain

NCT02800759 is registered in ClinicalTrials.gov with Seoul National University as lead sponsor.

NCT NCT02800759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Minimal Effective Dose of Cis-9-cetylmyristoleate (CMO) in Persons Presenting With Knee Joint Pain
Lead sponsor
Seoul National University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2013
Completion date
July 31, 2014
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

knee pain intermittent